WHO ICTRP trial
Investigation of the effect of curcumin in Multiple Sclerosis
IRCT20200614047766N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20200614047766N1 |
|---|---|
| Public title | Investigation of the effect of curcumin in Multiple Sclerosis |
| Scientific title | The effect of Curcumin on Oxidant , Antioxidant factors ,Liver ,Kidney tests serum , Clinical signs and symptoms of MultipleSclerosis patients |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Multiple Sclerosis. Demyelinating diseases of the central nervous system |
| Interventions | Intervention 1: Intervention group: Intervention group: MS patients who take Corkomine oral capsule for 3 months at a dose of 370 mg, take one a day at the beginning of the study and then take it twice a day. It has high antioxidant… |
| Registration date | Jun 30, 2020 |
| Target size | 96 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: